Oxford PharmaGenesis Revenue and Competitors

Oxford, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Oxford PharmaGenesis's estimated annual revenue is currently $128.6M per year.(i)
  • Oxford PharmaGenesis's estimated revenue per employee is $274,872

Employee Data

  • Oxford PharmaGenesis has 468 Employees.(i)
  • Oxford PharmaGenesis grew their employee count by -12% last year.

Oxford PharmaGenesis's People

NameTitleEmail/Phone
1
Project and Support OfficerReveal Email/Phone
2
EVPReveal Email/Phone
3
EVPReveal Email/Phone
4
Associate Account DirectorReveal Email/Phone
5
Senior Account ManagerReveal Email/Phone
6
US Value Demonstration Practice LeadReveal Email/Phone
7
Dir Communications Reveal Email/Phone
8
ChairmanReveal Email/Phone
9
Dir CommercialReveal Email/Phone
10
Managing DirReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M26510%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M4752%N/AN/A
#4
$20.9M893%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M62-67%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M369%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Oxford PharmaGenesis?

Oxford PharmaGenesis is a HealthScience communications consultancy providing services to the healthcare industry, professional societies and patient groups. Founded in 1998, Oxford PharmaGenesis is proud to be an independently owned consultancy in a sector increasingly populated by corporate communications conglomerates. Now employing more than 250 dedicated HealthScience experts in offices in Oxford, London, Philadelphia, Cardiff and Basel, Oxford PharmaGenesis is a preferred supplier to 9 of the top 10 global pharmaceutical companies. Our diverse client list comprises over 50 healthcare organizations, including pharmaceutical, devices, diagnostic and nutraceutical companies, and professional societies, patient groups and academic institutions. Contact us to find out how we apply powerful thinking, dedicated to your success.

keywords:N/A

N/A

Total Funding

468

Number of Employees

$128.6M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oxford PharmaGenesis News

2022-04-17 - All-Star Speaker Lineup for Medical Affairs Professional Society (MAPS) 2022 EMEA Annual Meeting

Chief Operating Officer, Oxford PharmaGenesis. Catrinel Galateanu: Executive Co-Chair VP, Head of Global Medical Affairs, UCB

2021-08-11 - Plain Language Results of DESTINY-Breast01 Clinical Study: CISCRP & OxfordPharmaGenesis Collaborate with Partners For Article in Future Oncology

The teams involved—Daiichi Sankyo, AstraZeneca, CISCRP, Oxford PharmaGenesis, and Dr. Modi —worked to ensure the PLSP was easy-to-read by adding creative visuals, tables and key questions answered about the DESTINY-Breast01 trial. BOSTON (PRWEB) August 11, 2021 CISCRP (Center for Information a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$67.7M46919%$246M
#2
N/A47120%N/A
#3
$137.6M54570%N/A
#4
$144.7M57333%N/A
#5
$132.3M588N/AN/A